Dr. Tomasz Marjanski graduated from the Medical University of Gdansk in 2004 and defended his Ph.D. thesis in 2009. In 2013, he was certified as a general thoracic surgeon. His scientific interest concentrates on risk assessment in thoracic surgery, minimally invasive treatment of lung cancer, chest trauma, and treatment of catamenial pneumothorax. Currently, he is involved in clinical trials of neoadjuvant and adjuvant immunotherapy in lung cancer patients. He participated in several clinical visits and fellowships in Norway, Italy, the Netherlands, the USA, Canada, and Turkey. He was awarded the ESTS Young Investigator’s Award in 2009. He is a member of ESTS and IASLC.